Food and non-food allergies are often associated with childhood, but millions of adults across the UK live with allergies too. Around 6% of the UK adult population has a clinically confirmed food…
Read more
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Read more
Following the Government’s announcement earlier this year of new allergy guidance to help keep children safe in schools, the Department for Education has now published its statutory guidance. The new requirements will…
Read more
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four…
Read more
The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community. As a charity supporting…
Read more
The National Institute for Health and Care Excellence (NICE) has published updated guidance on the assessment and referral of people following emergency treatment for anaphylaxis. This new guideline replaces NICE guideline CG134…
Read more
Anaphylaxis UK and Allergy UK to merge, creating a stronger, unified voice for people living with allergy and anaphylaxis. Anaphylaxis UK and Allergy UK today announce their intention to merge on the 1st of October, bringing…
Read more
A new international review has highlighted important inequalities in the prevalence, management, and outcomes of IgE-mediated food allergies among children from different ethnic backgrounds. The scoping review, published in the World Allergy…
Read more
New research from the University of Bristol and Bristol Royal Hospital for Children has highlighted critical delays in the use of adrenaline auto-injectors (AAIs) in children experiencing fatal food-induced anaphylaxis, prompting calls for urgent…
Read more